NLRP3 and sarcoma: 3′methylcholanthrene (MCA)-induced sarcomas in mice deficient in NLRP3 had decreased tumor burden compared to wild-type mice, attributed to NLRP3-mediated suppression of NK cell immune surveillance [180].